Form D · Pharmaceuticals
PLx Pharma Inc.
Sparta, NJ · CIK 0001497504
Offering snapshot reported Nov 30, 2020 · SEC filing
- Reported sold
- $18M Offering amount: $18M
- Investors reported
- 25 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 18, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 30, 2020 | Initial | $18,008,599 | No comparison | 25 | SEC filing |
| May 29, 2020 | Initial | $8,000,000 | No comparison | 3 | SEC filing |
| Mar 4, 2019 | Initial | $15,000,000 | No comparison | 2 | SEC filing |
| Jun 28, 2017 | Initial | $18,191,869 | No comparison | 37 | SEC filing |
| Jul 22, 2013 | Initial | $2,750,000 | No comparison | 28 | SEC filing |
| Feb 25, 2013 | Initial | $930,000 | No comparison | 8 | SEC filing |
| Apr 23, 2012 | Initial | $507,500 | No comparison | 16 | SEC filing |
| Nov 7, 2011 | Amendment | $2,740,000 | $1,670,000vs Jul 30, 2010 | 34 | SEC filing |
| Jul 30, 2010 | Initial | $1,070,000 | No comparison | 23 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.02M
- Finders' fees
- $0
- Form D file number
- 021-381708
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Raymond James & Associates, Inc. | 705 |
Source: Form D, filed Nov 30, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gary Balkema | Director |
| Anthony Bartsh | Director |
| Kirk Calhoun | Director |
| Robert Casale | Director |
| Christopher Coughlin | Director |
| Jack Dean | Director |
| Efthymios Deliargyris | Executive |
| Robert J. De Luccia | Director, Executive, Promoter |
| Michael Duffy | Director |
| Natasha Giordano | Director, Executive |
| John Hadden | Director |
| John W. Hadden Ii | Director |
| Steven Hurd | Director |
| David Jorden | Executive |
| Milos Koterec | Director |
| John Leone | Director |
| David Luci | Director |
| William J. Mc Sherry, Jr. | Director |
| Gary Mossman | Executive |
| Rita O'connor | Executive |
| John Terrana | Director |
| Michael J. Valentino | Director, Executive |
| Ellen Zaroff | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
9 Fishers Lane Suite E
Sparta, NJ, 07871
Sparta, NJ, 07871